These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

207 related articles for article (PubMed ID: 20570743)

  • 101. Response to letter to the editor: Statistical issues of QT prolongation assessment based on linear concentration modeling by Yi Tsong et al.
    Wang Y; Garnett C
    J Biopharm Stat; 2010 May; 20(3):689-92; author reply 693-7. PubMed ID: 20358447
    [No Abstract]   [Full Text] [Related]  

  • 102. A new screening model for safety evaluation of superantigen-antibody recombinant fusion proteins (mAb Fab-SEA/E) using telemetric monitoring in conscious rabbits.
    Ilbäck NG; Persson R; Gunnarsson K; Stålhandske T
    J Pharmacol Toxicol Methods; 2002; 48(1):31-9. PubMed ID: 12750039
    [TBL] [Abstract][Full Text] [Related]  

  • 103. Revisit the combination validation test of Tsong et al. for thorough QT/QTc clinical trials.
    Sun GG; Quan H
    J Biopharm Stat; 2010 May; 20(3):683-7; author reply 688. PubMed ID: 20358445
    [No Abstract]   [Full Text] [Related]  

  • 104. A pharmacological characterization of electrocardiogram PR and QRS intervals in conscious telemetered rats.
    Adeyemi O; Parker N; Pointon A; Rolf M
    J Pharmacol Toxicol Methods; 2020; 102():106679. PubMed ID: 32014539
    [TBL] [Abstract][Full Text] [Related]  

  • 105. Evaluation of levocetirizine in beagle dog and cynomolgus monkey telemetry assays: Defining the no QTc effect profile by timepoint and concentration-QTc analysis.
    Engwall MJ; Baublits J; Chandra FA; Jones ZW; Wahlstrom J; Chui RW; Vargas HM
    Clin Transl Sci; 2023 Mar; 16(3):436-446. PubMed ID: 36369797
    [TBL] [Abstract][Full Text] [Related]  

  • 106. A comparison of three software platforms for automated ECG analysis.
    Chui RW; Vargas HM
    J Pharmacol Toxicol Methods; 2009; 60(1):28-38. PubMed ID: 19467337
    [TBL] [Abstract][Full Text] [Related]  

  • 107. An integrative pharmacokinetic-cardiovascular physiology modelling approach based on in vivo dog studies including five reference compounds.
    Wallman M; Borghardt JM; Martel E; Pairet N; Markert M; Jirstrand M
    J Pharmacol Toxicol Methods; 2022; 115():107171. PubMed ID: 35398273
    [TBL] [Abstract][Full Text] [Related]  

  • 108. A comparison of the performance of contemporary, historical, and cross-lab controls in QTc assessment in conscious nonhuman primates.
    Abernathy MM; Best DD; Leishman DJ
    J Pharmacol Toxicol Methods; 2024; 127():107510. PubMed ID: 38705245
    [TBL] [Abstract][Full Text] [Related]  

  • 109. Background variability in standard clinical pathology biomarkers in beagle dogs instrumented with chronic indwelling telemetry devices.
    Baird TJ; Aulbach A; O'Donohue KP; Yoder JD; Dalton JA; Gauvin DV
    J Pharmacol Toxicol Methods; 2014; 69(3):223-8. PubMed ID: 24508734
    [TBL] [Abstract][Full Text] [Related]  

  • 110. QT PRODACT: inter-facility variability in electrocardiographic and hemodynamic parameters in conscious dogs and monkeys.
    Sasaki H; Shimizu N; Suganami H; Yamamoto K
    J Pharmacol Sci; 2005; 99(5):513-22. PubMed ID: 16493191
    [TBL] [Abstract][Full Text] [Related]  

  • 111. An optimised neurobehavioural observation battery integrated with the assessment of cardiovascular function in the beagle dog.
    Moscardo E; Fasdelli N; Giarola A; Tontodonati M; Dorigatti R
    J Pharmacol Toxicol Methods; 2009; 60(2):198-209. PubMed ID: 19467338
    [TBL] [Abstract][Full Text] [Related]  

  • 112. Overview of electrocardiographic and cardiovascular safety data for sparfloxacin. Sparfloxacin Safety Group.
    Jaillon P; Morganroth J; Brumpt I; Talbot G
    J Antimicrob Chemother; 1996 May; 37 Suppl A():161-7. PubMed ID: 8737135
    [TBL] [Abstract][Full Text] [Related]  

  • 113. Improving the in Vivo QTc assay: The value of implementing best practices to support an integrated nonclinical-clinical QTc risk assessment and TQT substitute.
    Vargas HM; Rossman EI; Wisialowski TA; Nichols J; Pugsley MK; Roche B; Gintant GA; Greiter-Wilke A; Kleiman RB; Valentin JP; Leishman DJ
    J Pharmacol Toxicol Methods; 2023; 121():107265. PubMed ID: 36997076
    [TBL] [Abstract][Full Text] [Related]  

  • 114. Evaluation of cardiovascular and ECG parameters in the normal, freely moving Göttingen Minipig.
    Stubhan M; Markert M; Mayer K; Trautmann T; Klumpp A; Henke J; Guth B
    J Pharmacol Toxicol Methods; 2008; 57(3):202-11. PubMed ID: 18434212
    [TBL] [Abstract][Full Text] [Related]  

  • 115. Evaluation of cardiovascular effects of intravenous robenacoxib in dogs.
    Desevaux C; Marotte-Weyn AA; Champeroux P; King JN
    J Vet Pharmacol Ther; 2017 Dec; 40(6):e62-e64. PubMed ID: 28457010
    [TBL] [Abstract][Full Text] [Related]  

  • 116. Effects of group housing on ECG assessment in conscious cynomolgus monkeys.
    Xing G; Lu J; Hu M; Wang S; Zhao L; Zheng W; Schofield J; Oldman K; Adkins D; Yu H; Platz S; Ren J; Skinner M
    J Pharmacol Toxicol Methods; 2015 Apr; 73():72-79. PubMed ID: 25901446
    [TBL] [Abstract][Full Text] [Related]  

  • 117. Cardiovascular and respiratory safety evaluation of
    Chu F; Ma H; Jin X
    Toxicol Mech Methods; 2019 Jul; 29(6):397-402. PubMed ID: 30676175
    [No Abstract]   [Full Text] [Related]  

  • 118. The Power of Phase I Studies to Detect Clinical Relevant QTc Prolongation: A Resampling Simulation Study.
    Ferber G; Lorch U; Täubel J
    Biomed Res Int; 2015; 2015():293564. PubMed ID: 26509147
    [TBL] [Abstract][Full Text] [Related]  

  • 119. Optimizing the experimental environment for dog telemetry studies.
    Klumpp A; Trautmann T; Markert M; Guth B
    J Pharmacol Toxicol Methods; 2006; 54(2):141-9. PubMed ID: 16730461
    [TBL] [Abstract][Full Text] [Related]  

  • 120. Best practice in the conduct of key nonclinical cardiovascular assessments in drug development: current recommendations from the Safety Pharmacology Society.
    Leishman DJ; Beck TW; Dybdal N; Gallacher DJ; Guth BD; Holbrook M; Roche B; Wallis RM
    J Pharmacol Toxicol Methods; 2012; 65(3):93-101. PubMed ID: 21907296
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.